Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001225208-16-032699)

Filing Details

Accession Number:: 0001225208-16-032699
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-05-05 17:27:25
Reporting Period:: 2016-05-03

Filing Date:: 2016-05-05
Accepted Time:: 2016-05-05 17:27:25
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
78003	Pfizer Inc	PFE	Pharmaceutical Preparations (2834)	135315170

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1194004	A Frank Damelio	Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017	Executive Vice President	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-05-03	87,079	$33.65	372,994	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	4,663	Indirect	By Rule 16b-3 Plan

Footnotes

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.